Germany Inserts Cost Considerations Into Technology Assessments
This article was originally published in The Gray Sheet
Executive Summary
Advisors to the German government have sketched an approach to evaluating medical technologies that could help set payment ceilings for devices and drugs under the country's government-based health insurance system